http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI1014433-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_639563cf4b5d2f3d7f30cd158bbd14dd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-16
filingDate 2010-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14800e754cf509b8cecc2d9dcfe06eed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cbef779ce133833f9bf8c242e489640
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_077f50c35e42356b2271f74b937446f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a40e8d2be28a5149cc3725156f721dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e78b8feee8a732d6085bf126af11377c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8411b2c68cbce4b81fa1fbf4a8ef5179
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_501c2a5ecd7e1cbd12714af54f17e388
publicationDate 2015-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI1014433-A2
titleOfInvention "derived from a pharmaceutically acceptable compound or salt, pharmaceutical or nutraceutical composition, and methods for treating a condition, for reducing development to tolerance to vasodilatory drugs, for stimulating mitochondrial function in cells, for improving muscle structure or function in an animal and the mitochondrial effects associated with exercise in an animal to enhance an animal's exercise capacity, muscle health and function, and the recovery of muscles from vigorous activity or damage associated with vigorous or sustained activity in an animal , and, uses of epicatechin or an epicatechin derivative, nicorandil or a nicorandil derivative and combinations thereof. "
priorityDate 2009-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410744664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID47528

Total number of triples: 34.